Advertisement

Topics

Companies Related to "Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older" [Most Relevant Company Matches] - Page: 5 RSS

16:47 EDT 23rd March 2019 | BioPortfolio

Here are the most relevant search results for "Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older" found in our extensive corporate database of over 50,000 company records.

Showing "Safety Immunogenicity Commercially Available Influenza Vaccine Formulation 2006" Companies 101–125 of 2,500+

Relevant

China Biopharma

China Biopharma Inc. (Stock Symbol: CBPC.OB) is a fast growing provider of human vaccine products in China. Through its wholly owned subsidiary, China Biopharma Limited, the Company owns the majority interest of Zhejiang Tianyuan Biotech Co., Ltd. The Company's current products consist of human vaccines against influenza (flu), epidemic hemorrhagic fever (HF), and Japanese Encephalitis (JE). With ...


Probably Relevant

Themis

Themis is developing urgently needed vaccines to prevent death and disability around the world. We lead in the development of a vaccine against chikungunya, a serious debilitating disease with global outbreak potential. Our innovation in vaccine technology has created a powerful platform and a growing pipeline addressing a broad range of infectious disease...

Aizant Drug Research Solutions (P) Ltd

Aizant is established by individuals with over 30 years of pharmaceutical industrial experience in the USA. Aizant provides comprehensive drug development resources and solutions for Pre-formulation, Formulation Development, Analytical Development, cGMP Scale-up, Stability, Bioavailability, Bioequivalence, Bioanalytical and Diagnostics for regulated and emerging markets.


Ventaira

Ventaira is an emerging specialty pharmaceutical company focused on developing pharmaceutical products for inhalation by utilizing its' novel proprietary electrohydrodynamic (EHD) aerosolization technology and formulation technologies to improve the profile of new or existing drugs. The device and technology lends itself to a range of drugs that can be formulated with parameters that are optimum f...

Zosano Pharma, Inc.

Zosano Pharma, Inc. is a privately held pharmaceutical company developing products based on its novel transdermal delivery technology for a broad range of therapeutic indications. Its lead clinical program, the ZP-PTH rapid delivery patch for the treatment of osteoporosis, is being developed as an alternative to daily injections. The company’s transde...

MedPharm Ltd

MedPharm is a 15,000-square-foot manufacturing, research and development and cannabis processing facility in Denver, Colorado. The company provides cannabis pharmaceutical-type products using Good Manufacturing Practices (GMP) that include pre-formulation, formulation development, commercial manufacturing, analytical method development, routine quality con...

Pure Protein, L.L.C.

Pure Protein is an HLA Center of Excellence - developing immunology tools for therapeutic and diagnostic applications in solid organ and stem cell transplantation, cross-reactive antibody screening, and major autoimmune diseases. Pure Protein was formed in 1999 to commercialize research developed at the University of Oklahoma Health Sciences Center. Pure T...

Themis Bioscience

Themis is developing urgently needed vaccines to prevent death and disability around the world. We lead in the development of a vaccine against chikungunya, a serious debilitating disease with global outbreak potential. Our innovation in vaccine and immune activation technology has created a powerful platform and a growing pipeline addressing a broad range...

VaxInnate Corporation

VaxInnate is a privately-held biotechnology company in Cranbury, NJ that is pioneering breakthrough technology for use in developing novel and proprietary vaccines. VaxInnate’s proprietary technology -- based upon a combination of toll-like receptor-mediated (TLR) immune enhancement and recombinant bacterial production of vaccine antigen -- conveys si...

The National Patient Safety Foundation

The National Patient Safety Foundation (NPSF) has been pursuing one mission since its founding in 1997 - to improve the safety of care provided to patients. As a central voice for patient safety, NPSF is committed to a collaborative, inclusive, multi-stakeholder approach in all that it does. NPSF is an independent, not-for-profit 501(c)(3) organization. To learn more about the work of the National...

Immunovaccine Inc.

Immunovaccine Inc. develops cancer immunotherapies and infectious disease vaccines based on the Company’s DepoVax™ platform, a patented formulation that provides controlled and prolonged exposure of antigens and adjuvant to the immune system. Immunovaccine has advanced two T cell activation therapies for cancer through Phase 1 human clinical trials ...

Egg Safety Center

The Egg Safety Center provides scientifically accurate information on food safety issues related to eggs. We work with egg producers to provide them with the most up to date information available and are dedicated to educating consumers on proper food handling to reduce the incidence of food-borne illness. For more information on egg safety visit www.eggsafety.org.

UL’s Integrated Health & Safety Institute

Founded in June 2015, UL’s Integrated Health & Safety Institute (IHSI) is the first private sector not-for-profit institute dedicated to advancing the integration of workplace health and safety programs. IHSI provides world-class research, guidance, standards, and education to assist employers in integrating their health, safety and worker well-being ...

Drug Safety Alliance

Founded in 2000, Drug Safety Alliance (DSA) provides patient safety and pharmacovigilance expertise to large and small pharmaceutical and biotechnology companies to help them develop safe drugs and improve patient safety. Driven by the highest ethical standards, DSA is uniquely focused to provide high-quality pre- and post-market drug safety services inclu...

AMINO GmbH

A fully integrated manufacturer of natural amino acids and other value-added ingredients derived mainly from vegetable sources, AMINO produces and formulates scientifically substantiated, safe and effective amino acid blends and active ingredients.More than 300 professionals, physicians and natural product chemists worldwide are dedicated to the needs of pharmaceutical and nutraceutical producers....

International Medica Foundation

The International Medica Foundation, which has the rights to RotaShield, is a nonprofit foundation that focuses on ensuring that a safe, effective and affordable rotavirus vaccine is clinically tested and then can be provided to families in need globally. The International Medica Foundation also aims to ensure that the manufacturing process for Rota...

Tercica

Tercica, Inc., based in Brisbane, Calif., is a biopharmaceutical company committed to improving endocrine health. We are helping patients by partnering with the scientific and medical community to develop and commercialize therapeutics for growth and other endocrine disorders. In January 2006, less than four years after Tercica was founded, we commercially launched Increlex™ (mecasermin [rDNA ...

TransForm Pharmaceuticals, Inc.

TransForm Pharmaceuticals brings new value to products by reinventing the industry’s approach to form and formulation, with deep scientific expertise in form and formulation, state-of-art high-throughput experimentation and informatics to maximize the clinical and commercial value. TransForm is distinctively positioned to expedite drug development to bring new and better products to the market, ...

AVAX Technologies, Inc.

AVAX Technologies, Inc. is a biotechnology company with operations in the United States and Europe. The Company is engaged in the research, clinical and commercial development of biological products and cancer therapeutics. AVAX’s AC Vaccine platform is a therapeutic cancer vaccine. In addition, the Company performs contract-manufacturing services for...

Sonus Pharmaceuticals, Inc.

Headquartered near Seattle, Washington, Sonus Pharmaceuticals, Inc. is focused on the development of cancer drugs that are designed to provide better efficacy, safety and tolerability, and ease of use. Sonus moved an oncology product candidate, SN2310, into a Phase 1 clinical trial in September 2006. For additional information on Sonus, including past news releases, please visit http://www.son...

UL’s Integrated Health and Safety Institute

Founded in June 2015, UL’s Integrated Health and Safety Institute (IHSI) is the first private sector not-for-profit institute dedicated to advancing the integration of workplace health and safety programs. IHSI provides world-class research, guidance, standards, and education to assist employers in integrating their health, safety and worker well-bein...

AC Vaccine technology

The AC Vaccine technology is a therapuetic treatment based on the concept of haptenization. This idea has a long history, beginning with the work of the immunologist and Nobel laureate Karl Landsteiner in the 1920’s. He and other scientists showed in animal models that attaching a small chemical (a hapten) to a protein allowed that protein to be recognized by the immune system even if the anim...

Accelerator Corp

VieVax Corp. is focused on commercializing a novel approach to vaccine development that is designed to overcome the limitations of existing vaccine technologies. These technologies, largely unchanged and unimproved for the past half-century, have consistently fallen short in addressing a number of critical issues, including: the spread of serious emerging infectious diseases, the emergence of trea...

ProImmune Ltd.

ProImmune is a private biotechnology company that specializes in providing products and services for antigen characterization, immune monitoring and the design of biological drugs with reduced immunogenicity risk. ProImmune has a wide range of customers, including leading pharmaceutical and biotechnology companies, as well as clinical and academic research...

Biota Holdings Limited

Biota is a leading anti-infective drug development company based in Melbourne Australia, with key expertise in respiratory diseases, particularly influenza. Biota developed the first-in-class neuraminidase inhibitor, zanamivir, subsequently marketed by GlaxoSmithKline as Relenza. Biota research breakthroughs have included novel nucleoside analogues designe...


More From BioPortfolio on "Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks